FDA
approval
· 2025-04-03
FDA Approved: SAPROPTERIN DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approved a supplemental application for Camber Pharmaceuticals' sapropterin dihydrochloride, establishing a generic version of the treatment for phenylketon…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for SAPROPTERIN DIHYDROCHLORIDE (SAPROPTERIN DIHYDROCHLORIDE)